Who founded Modulari-T?

Modulari-T was founded by David White, Stephanie Mok in 2021.

Who are Modulari-T's investors?

Modulari-T's investors include Metaplanet, Y Combinator, BoxOne Ventures.

Where is Modulari-T headquartered?

Modulari-T is headquartered in Montreal, CA.

Modulari-T

YC W23

Montreal, CA · Founded 2021 · 4 employees · 3 known investors

Find your way into Modulari-T

542 people in our graph share verified history with the Modulari-T team — schools, employers, funds. One of them is your warm intro.

Anne-Sophie Gauvinunlockedknows David White · together at Université de Montréal (overlapped)

×4knows the team · via McGill University

knows the team · via Western University

×4knows the team · via Concordia University

knows the team · via Université de Montréal

knows the team · via Institut de recherches cliniques de Montréal (IRCM) / Montreal Clinical Research Institute

Modulari-T develops proprietary cell therapy technologies, including the MARC receptor and MoVe platform, based on primary research into immune system architecture. The company serves the cell therapy and immunotherapy market.

Also known as Modulari-T Biosciences

Biotech Deep Tech Healthtech Medical Devices Gene Therapy Cell Therapy Synthetic Biology OncologyCanadaUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (W23)

Modulari-T was founded in 2021 by David White and Stephanie Mok.

David White inCo-founder · President and CSODavid White completed a PhD where he researched protein receptors and their mechanisms for altering cellular behavior, which led him to found Modulari-T.

Stephanie Mok inCo-Founder & COOStephanie Mok is co-founder and COO at Modulari-T, where she applies expertise in synthetic biology, 3D cell culture systems, and biomaterials. She holds a PhD in chemical engineering.

Investors · 3

MetaplanetTallinn · $500K – $10M

Y CombinatorSan Francisco · $500K

BoxOne VenturesreportedMontréal · $500K

Competitors · 2

by search overlap

Modulo Bio11 shared keywordsModulo is a biotech company focused on the neuroimmune system, developing treatments for brain and central nervous system disorders. It uses multiple neurobiology models and computational biology to study neuroimmune mechanisms and discover new therapies for patients affected by neurological disease.

Create9 shared keywordsCREATE Medicines is a clinical-stage biotech company that develops in vivo mRNA immune cell programming therapies. The company focuses on RNA therapeutics and immune engineering for cancer, autoimmune disease, and transplant rejection applications.

Companies competing with Modulari-T for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Modulari-T 🧬 Unleash the full power of the immune systemycombinator.com · Jan 2023

Frequently asked questions

What does Modulari-T do?: Modulari-T develops proprietary cell therapy technologies, including the MARC receptor and MoVe platform, based on primary research into immune system architecture. The company serves the cell therapy and immunotherapy market.
Who founded Modulari-T?: Modulari-T was founded by David White, Stephanie Mok in 2021.
Who are Modulari-T's investors?: Modulari-T's investors include Metaplanet, Y Combinator, BoxOne Ventures.
Where is Modulari-T headquartered?: Modulari-T is headquartered in Montreal, CA.